Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy

Cell Biochemistry and Biophysics

Volumn 67, Issue 3, 2013, Pages 865-873

  Sartini, Davide ^a   Morganti, Stefano ^a   Guidi, Elena ^a   Rubini, Corrado ^a   Zizzi, Antonio ^a   Giuliante, Rachela ^a   Pozzi, Valentina ^a   Emanuelli, Monica ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Enzyme activity; Gene expression; Lung cancer; NNMT; Tumor marker

Indexed keywords

ANTINEOPLASTIC AGENT; MESSENGER RNA; NICOTINAMIDE METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER STAGING; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROTEIN BINDING; UPREGULATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NICOTINAMIDE N-METHYLTRANSFERASE; PROTEIN BINDING; RNA, MESSENGER; UP-REGULATION;

EID: 84888387501     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9574-z     Document Type: Article

References (40)

1. Feng, J., Zhang, X., Zhu, H., Wang, X., Ni, S., & Huang, J. (2012). FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT. PLoS One, 7, e39937.
2. Wiśniewski, A., Jankowska, R., Passowicz-Muszyńska, E., Wiśniewska, E., Majorczyk, E., Nowak, I., et al. (2012). KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population. Human Immunology, 73, 927-931.
3. Jang, I., Jeon, B. T., Jeong, E. A., Kim, E. J., Kang, D., Lee, J. S., et al. (2012). Pak1/LIMK1/Cofilin Pathway Contributes to Tumor Migration and Invasion in Human Non-Small Cell Lung Carcinomas and Cell Lines. Korean Journal of Physiology and Pharmacology, 16, 159-165.
4. Raghavan, P., Tumati, V., Yu, L., Chan, N., Tomimatsu, N., Burma, S., et al. (2012). AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells. International Journal of Radiation Oncology Biology Physics, 84, e507-e514.
5. Lokk, K., Vooder, T., Kolde, R., Välk, K., Võsa, U., Roosipuu, R., et al. (2012). Methylation markers of early-stage non-small cell lung cancer. PLoS One, 7, e39813.
6. Aksoy, S., Szumlanski, C. L., & Weinshilboum, R. M. (1994). Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. Journal of Biological Chemistry, 269, 14835-14840.
7. Peng, Y., Sartini, D., Pozzi, V., Wilk, D., Emanuelli, M., & Yee, V. C. (2011). Structural basis of substrate recognition in human nicotinamide N-methyltransferase. Biochemistry, 50, 7800-7808.
8. Sartini, D., Muzzonigro, G., Milanese, G., Pierella, F., Rossi, V., & Emanuelli, M. (2006). Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma. Journal of Urology, 176, 2248-2254.
9. Sartini, D., Santarelli, A., Rossi, V., Goteri, G., Rubini, C., Ciavarella, D., et al. (2007). Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Molecular Medicine, 13, 415-421.
10. Sartini, D., Muzzonigro, G., Milanese, G., Pozzi, V., Vici, A., Morganti, S., et al. (2012). Upregulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: Potential for the development of a urine-based diagnostic test. Cell Biochemistry and Biophysics, 65, 473-483.
11. Emanuelli, M., Santarelli, A., Sartini, D., Ciavarella, D., Rossi, V., Pozzi, V., et al. (2010). Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma. Histology and Histopathology, 25, 15-20.
12. Pozzi, V., Mazzotta, M., Lo Muzio, L., Sartini, D., Santarelli, A., Renzi, E., et al. (2011). Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. International Journal of Immunopathology & Pharmacology, 24, 69-77.
13. Sartini, D., Pozzi, V., Renzi, E., Morganti, S., Rocchetti, R., Rubini, C., et al. (2012). Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. Biological Chemistry, 393, 505-511.
14. Balducci, E., Orsomando, G., Polzonetti, V., Vita, A., Emanuelli, M., Raffaelli, N., et al. (1995). NMN adenylyltransferase from bull testis: purification and properties. Biochemical Journal, 310, 395-400.
15. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
16. Santarelli, L., Strafella, E., Staffolani, S., Amati, M., Emanuelli, M., Sartini, D., et al. (2011). Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma. PLoS One, 6, e18232.
17. Thomas, A., Rajan, A., Lopez-Chavez, A., Wang, Y., & Giaccone, G. (2012). From targets to targeted therapies and molecular profiling in non-small cell lung carcinoma. Annals of Oncology, 24, 577-585.
18. Chin, L. P., Soo, R. A., Soong, R., & Ou, S. H. (2012). Targeting ROS1 with anaplastic lymphoma kinase inhibitors: A promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer. Journal of Thoracic Oncology, 7, 1625-1630.
19. Okamoto, H., Ishikawa, A., Yoshitake, Y., Kodama, N., Nishimuta, M., Fukuwatari, T., et al. (2003). Diurnal variations in human urinary excretion of nicotinamide catabolites: effects of stress on the metabolism of nicotinamide. American Journal of Clinical Nutrition, 77, 406-410.
20. Yao, M., Tabuchi, H., Nagashima, Y., Baba, M., Nakaigawa, N., Ishiguro, H., et al. (2005). Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. Journal of Pathology, 205, 377-387.
21. Markert, J. M., Fuller, C. M., Gillespie, G. Y., Bubien, J. K., McLean, L. A., Hong, R. L., et al. (2001). Differential gene expression profiling in human brain tumors. Physiological Genomics, 5, 21-33.
22. Jang, J. S., Cho, H. Y., Lee, Y. J., Ha, W. S., & Kim, H. W. (2004). The differential proteome profile of stomach cancer: Identification of the biomarker candidates. Oncology Research, 14, 491-499.
23. Xu, J., Moatamed, F., Caldwell, J. S., Walker, J. R., Kraiem, Z., Taki, K., et al. (2003). Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells. Journal of Clinical Endocrinology and Metabolism, 88, 4990-4996.
24. Roessler, M., Rollinger, W., Palme, S., Hagmann, M. L., Berndt, P., Engel, A. M., et al. (2005). Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clinical Cancer Research, 11, 6550-6557.
25. Rogers, C. D., Fukushima, N., Sato, N., Shi, C., Prasad, N., Hustinx, S. R., et al. (2006). Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs. Cancer Biology & Therapy, 5, 1383-1389.
26. Debigaré, R., Maltais, F., Côté, C. H., Michaud, A., Caron, M. A., Mofarrahi, M., et al. (2008). Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting. Chronic Obstructive Pulmonary Disease, 5, 75-84.
27. Mateuszuk, Ł., Khomich, T. I., Słomińska, E., Gajda, M., Wójcik, L., Łomnicka, M., et al. (2009). Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis. Pharmacological Report, 61, 76-85.
28. Williams, A. C., & Ramsden, D. B. (2005). Autotoxicity, methylation and a road to the prevention of Parkinson's disease. Journal of Clinical Neuroscience, 12, 6-11.
29. Wu, Y., Siadaty, M. S., Berens, M. E., Hampton, G. M., & Theodorescu, D. (2008). Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene, 27, 6679-6689.
30. Parsons, R. B., Aravindan, S., Kadampeswaran, A., Evans, E. A., Sandhu, K. K., Levy, E. R., et al. (2011). The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of Complex I inhibitors. Biochemical Journal, 436, 145-155.
31. Tang, S. W., Yang, T. C., Lin, W. C., Chang, W. H., Wang, C. C., Lai, M. K., et al. (2011). Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis, 32, 138-145.
32. Zhang, J. (2003). Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? BioEssays, 25, 808-814.
33. Kassem, H Sh, Sangar, V., Cowan, R., Clarke, N., & Margison, G. P. (2002). A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer. International Journal of Cancer, 101, 454-460.
34. D'Andrea, F. P., Safwat, A., Kassem, M., Gautier, L., Overgaard, J., & Horsman, M. R. (2011). Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. Radiotherapy and Oncology, 99, 373-378.
35. Audrito, V., Vaisitti, T., Rossi, D., Gottardi, D., D'Arena, G., Laurenti, L., et al. (2011). Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Research, 71, 4473-4483.
36. Bryniarski, K., Biedron, R., Jakubowski, A., Chlopicki, S., & Marcinkiewicz, J. (2008). Anti-inflammatory effect of 1-methylnicotinamide in contact hypersensitivity to oxazolone in mice; involvement of prostacyclin. European Journal of Pharmacology, 578, 332-338.
37. Chlopicki, S., Swies, J., Mogielnicki, A., Buczko, W., Bartus, M., Lomnicka, M., et al. (2007). 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. British Journal of Pharmacology, 152, 230-239.
38. Bartuś, M., Łomnicka, M., Kostogrys, R. B., Kaźmierczak, P., Watała, C., Słominska, E. M., et al. (2008). 1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats. Pharmacological Report, 60, 127-138.
39. Brzozowski, T., Konturek, P. C., Chlopicki, S., Sliwowski, Z., Pawlik, M., Ptak-Belowska, A., et al. (2008). Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves. Journal of Pharmacology and Experimental Therapeutics, 326, 105-116.
40. Tomida, M., Mikami, I., Takeuchi, S., Nishimura, H., & Akiyama, H. (2009). Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. Journal of Cancer Research and Clinical Oncology, 135, 1223-1229.